关键词: Diagnosis Hypertrophic cardiomyopathy Implantable defibrillator Reflex syncope Risk stratification Sudden cardiac death Syncope

Mesh : Humans Defibrillators, Implantable / adverse effects Risk Assessment Cardiomyopathy, Hypertrophic / complications diagnosis therapy Death, Sudden, Cardiac / epidemiology prevention & control etiology Syncope / diagnosis etiology therapy Risk Factors

来  源:   DOI:10.1016/j.ijcard.2022.10.153

Abstract:
Syncopal events in patients with hypertrophic cardiomyopathy (HCM) are of concern as they are a vital consideration in algorithms for risk stratification for sudden cardiac death (SCD) and ICD implantation. However, the cause of syncope is often under-investigated and/or unexplained. Current syncope guidelines do not provide a detailed definition of unexplained syncope. To address this important gap, an international panel of experts in the field of both syncope and HCM wrote a consensus document with the aim of providing practical guidance for the diagnosis and management of syncope in patients with HCM.
摘要:
肥厚型心肌病(HCM)患者的晕厥事件值得关注,因为它们是心源性猝死(SCD)和ICD植入风险分层算法中的重要考虑因素。然而,晕厥的原因往往是调查不足和/或无法解释。目前的晕厥指南没有提供不明原因晕厥的详细定义。为了解决这一重要差距,晕厥和HCM领域的国际专家小组撰写了一份共识文件,旨在为HCM患者晕厥的诊断和治疗提供实践指导.
公众号